Article

Eyemaginations opens international HQ

Eyemaginations has enhanced its commitment to the international community by opening its international headquarters in Erlangen, Germany.

Towson, MD-Eyemaginations has enhanced its commitment to the international community by opening its international headquarters in Erlangen, Germany.

Leading the operation is Robert Habel, vice president, international sales and general manager, Eyemaginations Europe GmbH. Habel comes to Eyemaginations with more than a decade of sales and marketing experience, most recently as director of international sales at WaveLight AG.

"This announcement represents the continuation of a very strong growth trend for Eyemaginations," said Jeffrey Peres, president and chief executive officer, Eyemaginations.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.